Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Equity (2021 - 2025)

Roivant Sciences' Return on Equity history spans 5 years, with the latest figure at 0.07% for Q3 2025.

  • For Q3 2025, Return on Equity rose 7.0% year-over-year to 0.07%; the TTM value through Sep 2025 reached 0.07%, up 7.0%, while the annual FY2025 figure was 0.07%, 12.0% up from the prior year.
  • Return on Equity reached 0.07% in Q3 2025 per ROIV's latest filing, up from 0.06% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.07% in Q1 2025 to a low of 0.72% in Q4 2022.
  • Average Return on Equity over 5 years is 0.26%, with a median of 0.22% recorded in 2021.
  • Peak YoY movement for Return on Equity: tumbled -45bps in 2022, then surged 69bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.27% in 2021, then crashed by -165bps to 0.72% in 2022, then soared by 83bps to 0.12% in 2023, then surged by 156bps to 0.07% in 2024, then rose by 1bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Return on Equity are 0.07% (Q3 2025), 0.06% (Q2 2025), and 0.07% (Q1 2025).